Adenomas productores de prolactina (lactotropo) En ausencia de tumor hipofisario debe des- que muestra un macroadenoma hipofisario (adenoma. Manejo de pacientes con diagnóstico de adenoma hipofisario productor de prolactina. Experiencia del Hospital San José. Diana Cristina. of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma. de un adenoma hipofisario productor de prolactina (PRL) o prolactinoma.

Author: Kagabei Goltim
Country: Malta
Language: English (Spanish)
Genre: Music
Published (Last): 28 January 2015
Pages: 450
PDF File Size: 8.56 Mb
ePub File Size: 11.24 Mb
ISBN: 650-9-87051-760-5
Downloads: 47150
Price: Free* [*Free Regsitration Required]
Uploader: Moogubei

There was a problem providing the content you requested

Services on Demand Journal. Once physiological causes such as pregnancy, systemic disorders such as primary hypothyroidism and the use of drugs with dopamine antagonistic actions such as metochlopramide have been ruled prolactnia, the most common cause of hyperprolactinemia is a PRL-secreting pituitary adenoma or prolactinoma.

No primeiro estudo, Reincke e cols 2 avaliaram 18 tumores, 11 maiores que 10mm e 7 menores que 10mm.

Diagnosis and hipofisairo of hyperprolactinemia: Spontaneous and medically induced cerebrospinal fluidleakage in the setting of pituitary adenomas: Prolactinomas resistant to standard doses of cabergoline: Cancer risk in hyperprolactinemia patients: Se describieron variables demogricas, clicas, seguimiento radiolico anual, prolactina PRL basal, a los 6 y 24 meses.

Hyperprolactinemia is a frequent neuroendocrinological condition that should be approached in an orderly and integral fashion, starting with a complete clinical history. In the cases of microprolactinomas and intrasselar macroprolactinomas, the treatment with dopaminergic agonists may be suspended after pregnancy is confirmed. To describe our experience in the Endocrinology Service hipofiaario Hospital San Josin the treatment of patients with prolactinoma who were seen between and A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas.


Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline. As quatro abordagens comparadas foram: QJM Jun; 6: Demographic and clinical variables were described, as well as radiological monitoring once yearly and basal prolactin PRL measurements at 6 and 24 months.

Prolactin; hyperprolactinemia; prolactinoma; pseudoprolactinoma; pituitary adenoma; neurosurgery; macroprolactina; dopamine agonist. Pituitary size in depression. However, the remission rate is low, possibly explained by the use of low doses of dopamine agonists. A paciente deve ser monitorada clinicamente a cada trimestre. The risk for breast cancer is not evidently increased in women prolacgina hyperprolactinemia.

[Current diagnosis and treatment of hyperprolactinemia].

Arch Intern Med ; The incidentaloma of the pituitary gland. The patients included suffered from pituitary adenoma documented by contrast magnetic resonance imaging cMRIwith serum Hipifisario ? Ann Intern Med ; Clinical treatment with dopamine agonists is the gold standard, with cabergoline as the first choice due to its greater efficiency and tolerability. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea.

High prolactin levels may be missed by immunoradiometric assay in prolactija with macroprolactinomas. En las personas con macroprolactinoma fue de 65 meses, con mediana de dosis acumulada de CAB de mg. Patterns of visual loss associated with pituitary macroadenomas. Outcomes of transsphenoidal surgery in prolactinomas: La poblaci atendida en el Hospital San Jostiene caracterticas similares a las registradas en la literatura; sin embargo, el porcentaje de remisi es bajo, lo cual, posiblemente estasociado al uso de bajas dosis de agonistas de dopamina.


[Current diagnosis and treatment of hyperprolactinemia].

J Clin Endocrinol Metab ; Twenty-four hour secretory patterns of prolactin in women. Mah PM, Webster J.

Como poderia ser feito esse seguimento? Hyperprolactinemia causes hypogonadism, menstrual irregularities or amenorrhea in women, low serum testosterone levels in men, and infertility and sexual dysfunction in both men and women. Multiple endocrine neoplasia type 1. Evaluation and treatment of the patient with a pituitary incidentaloma.

Shimatsu A, Hattori N. Gostaria de perguntar sobre o papel da dosagem da subunidade a em incidentalomas?

Macroprolactina e incidentaloma hipofisário

Prospective study of high-dose cabergoline treatment of prolactinomas in patients. Prolactinomas resistant to standard doses of cabergoline: Temozolomide in the management of dopamine agonist-resistant prolactinomas. Diagnosis and treatment of hyperprolactinemia: Clin Endocrinol Oxf ;67 3: